Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Lorcaserin HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai ends lorcaserin development in Dravet syndrome
    Eisai ends lorcaserin development in Dravet syndrome

    18 Nov 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/eisai-sunsets-development-access-program-withdrawn-obesity-med-dravet-syndrome

    FIERCE PHARMA
    18 Nov 2024
    Share Share
    Taiwan pulls weight-loss drug from market over cancer concerns
    Taiwan pulls weight-loss drug from market over cancer concerns

    16 Jul 2020

    // Ching-Tse Cheng TWAIWANNNEWS

    https://www.taiwannews.com.tw/en/news/3968107

    Ching-Tse Cheng TWAIWANNNEWS
    16 Jul 2020
    Share Share
    Belviq, Belviq XR by Eisai - FDA Requests Withdrawal of Weight-Loss Drug
    Belviq, Belviq XR by Eisai - FDA Requests Withdrawal of Weight-Loss Drug

    14 Feb 2020

    // FDA

    https://www.fda.gov/safety/medical-product-safety-information/belviq-belviq-xr-lorcaserin-eisai-drug-safety-communication-fda-requests-withdrawal-weight-loss-drug

    FDA
    14 Feb 2020
    Share Share
    Eisai will pull Belviq off U.S. shelves on cancer concerns
    Eisai will pull Belviq off U.S. shelves on cancer concerns

    14 Feb 2020

    // Kyle Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/eisai-will-pull-belviq-off-u-s-shelves-after-trial-shows-increased-cancer-risk

    Kyle Blankenship FIERCE PHARMA
    14 Feb 2020
    Share Share
    FDA Warns of Potential Cancer Risk With Weight Loss Drug
    FDA Warns of Potential Cancer Risk With Weight Loss Drug

    14 Jan 2020

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2020/1/fda-warns-of-potential-cancer-risk-with-weight-los

    Zachary Brennan RAPS
    14 Jan 2020
    Share Share
    Zydus Receives USFDA Tentative Approval For Lorcaserin Hydrochloride Tablet
    Zydus Receives USFDA Tentative Approval For Lorcaserin Hydrochloride Tablet

    03 Dec 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=119735&sid=2

    PHARMABIZ
    03 Dec 2019
    Share Share